US FDA allows warnings on OTC benzocaine

13 May 2014 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) has told manufacturers of OTC oral healthcare products containing benzocaine that product labelling can include a warning about methemoglobinemia.

Click tags below for more information on topics:

FDA CHPA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: